Therapy of stable angina pectoris - The uncomplicated patient

被引：25

作者：

Abrams, J ^{[1
]}

Thadani, U

机构：

[1] Univ New Mexico, Div Cardiol, Dept Internal Med, Albuquerque, NM 87131 USA

[2] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Cardiol Sect, Oklahoma City, OK 73104 USA

[3] Vet Adm Med Ctr, Oklahoma City, OK 73104 USA

来源：

CIRCULATION | 2005年 / 112卷 / 15期

关键词：

D O I：

10.1161/CIRCULATIONAHA.104.526699

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E255 / E259

页数：5

共 25 条

[21] Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol [J].

Rubins, HB ;

Robins, SJ ;

Collins, D ;

Fye, CL ;

Anderson, JW ;

Elam, MB ;

Faas, FH ;

Linares, E ;

Schaefer, EJ ;

Schectman, G ;

Wilt, TJ ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) :410-418

[22] Treatment of stable angina [J].

Thadani, U .

CURRENT OPINION IN CARDIOLOGY, 1999, 14 (04) :349-358

[23]

Thadani U., 2003, AM J CARDIOVASC DRUG, V3, P11

[24]

Thadani Udho, 2004, Journal of Cardiovascular Pharmacology and Therapeutics, V9, pS11, DOI 10.1177/107424840400900103

[25] Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris [J].

Zouridakis, E ;

Avanzas, P ;

Arroyo-Espliguero, R ;

Fredericks, S ;

Kaski, JC .

CIRCULATION, 2004, 110 (13) :1747-1753

← 1 2 3 →